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Fatigue in adults with primary Antiphospholipid Syndrome: findings from a mixed 
methods study 
 
ABSTRACT 
Objective: To explore the experience and impact of fatigue in adults with primary 
Antiphospholipid Syndrome (pAPS). 
Methods: This sequential, explanatory mixed-methods study enrolled adults with ≥6-month 
history of pAPS. Consenting participants completed the Functional Assessment of Chronic 
Illness Therapy–Fatigue subscale (FS), Multi-Dimensional Perceived Social Support Scale 
(MSPSS), Patient Health Questionnaire (PHQ9), Pittsburgh Sleep Quality Index (PSQI), 
International Physical Activity Questionnaire (IPAQMETS). Relationships between FS and other 
variables were explored with multiple linear regression. Interviews were conducted with a 
subgroup of participants and data analysed thematically. 
Results: 103 participants were recruited (mean (Standard Deviation) 50.3 (10.1) years, 18 males). 
62% of participants reported severe fatigue.  Greater fatigue was associated with lower mood, 
physical inactivity, poorer sleep quality and lower perceived social support. The best-fit model 
explained 56% of the variance in FS (adjusted R2=0.560, F(3,74)=33.65, p>0.001) and included 
PHQ9, and IPAQMETS as significant predictors, and PSQI as a non-significant predictor.  
Twenty participants completed interviews. Three key themes were identified: Characteristics of 
fatigue, Impact on life, Coping strategies. 
Conclusion: Fatigue was a common symptom of pAPS and challenging to manage. Other 
factors, particularly mood and physical activity, influenced fatigue. Evidence-based self-
management interventions are needed.  
KEY WORDS: Antiphospholipid syndrome, fatigue, mixed methods 
  
Fatigue in pAPS_mixed methods 
 
INTRODUCTION 
Antiphospholipid syndrome is an autoimmune, prothrombotic disorder, which occurs as a 
distinct clinical syndrome in isolation (primary antiphospholipid syndrome (pAPS)) or with other 
rheumatic and musculoskeletal diseases (RMDs) e.g. Systemic lupus erythematosus (SLE) [1]. 
The incidence of antiphospholipid syndrome is approximately 5/100,000 people annually and 
the prevalence is 40–50/100,000 people [1]. More women than men are affected (female:male 
ratio 5:1), and there is no racial prevalence for pAPS  [2, 3]. Its clinical spectrum includes venous 
and/or arterial thromboses and pregnancy morbidity in the presence of antiphospholipid 
antibodies (e.g. lupus anticoagulant, anticardiolipin antibodies, anti-ß2 glycoprotein-I antibodies). 
People with pAPS also experience other symptoms, such as fatigue, low mood and have 
difficulty keeping physically active [4, 5]. 
 
Chronic fatigue is an unpleasant, abnormal or excessive whole-body tiredness, disproportionate 
to or unrelated to activity or exertion and present for more than one month. It is not relieved 
easily by sleep or rest [6, 7]. Fatigue is a common symptom of RMDs and adversely affects an 
individual’s health status, physical and social function. Studies in RMDs (e.g. Rheumatoid 
arthritis (RA) [8], SLE [9]) and other long-term conditions (e.g. Multiple Sclerosis [10]) have 
highlighted the impact and importance of fatigue [11-13].  
 
The aetiology of fatigue is poorly understood.  Theoretical models propose fatigue is a multi-
causal, multi-dimensional symptom where disease-related (e.g. disease activity), 
cognitive/emotional (e.g. mood), physical and social factors (e.g. physical activity, social support) 
interact with each other [14-16].  In other RMDs,  aspects outside the direct disease effects 
account for more of the variation of fatigue than condition-related features [15, 17, 18].  
 
For this study, key factors which influence fatigue in other RMDs were identified. Low mood is 
common in people with RMDs and is consistently correlated with higher fatigue [16, 18, 19]. 
Low mood is also linked with sleep disturbance and evidence suggests that poor sleep quality 
influences fatigue levels [15, 20, 21]. Physical activity tends to be low in people with RMDs [22, 
23]  and physical inactivity is associated with higher fatigue [15, 24, 25]. This relationship may be 
mediated by mood, sleep or obesity [15, 24, 25]. Social support from family, friends or significant 
others (e.g. healthcare professionals) may also influence fatigue [16, 26]. 
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Few studies have explored the experience and impact of fatigue in people with pAPS and it is 
rarely acknowledged in evidence-based management recommendations [27]. To inform the 
development of non-pharmacological interventions, a mixed-methods approach that comprises 
quantitative data to investigate the relationships between fatigue and key variables and qualitative 
data, to gain greater insight into these interactions and the experience and impact of fatigue is 
needed.  This mixed-methods study aimed to explore the experience and impact of fatigue in 
adults with pAPS. 
 
METHODS 
Study design 
This mixed-methods study adopted a sequential, explanatory design informed by the priority 
sequence model [28, 29]. In this model, an initial decision about the priority of a quantitative or 
qualitative method is taken; next, the sequence determines whether the complementary method 
serves either as a preliminary or as a follow-up phase. For this study, a cross-sectional survey was 
conducted to investigate relationships between fatigue and key psychosocial variables then, 
follow-up qualitative data were collected to explore the interactions identified in the quantitative 
phase and the direct experience and impact of fatigue in people with pAPS.  
The study gained governance approval from North of Scotland Research Ethics Committee 
(14/NS/0026, 02/07/2014) and Research and Innovation from Guy’s and St Thomas’ Hospital 
NHS Foundation Trust (12/03/2015) 
Quantitative phase 
Participants and data collection 
Patients were eligible to be enrolled onto the study if they were: aged ≥18 years with pAPS 
(Sydney classification criteria [30]) for ≥6 months and had adequate verbal and written English 
language.  
Patients who had other autoimmune rheumatic or inflammatory co-morbid conditions, 
malignancy, active chronic infections, current alcohol and/or drug abuse/dependence, Body 
Mass Index >30 recorded in their medical records and/or were pregnant/breastfeeding, were 
excluded. Patients with positive antinuclear antibodies were also excluded as this may indicate 
APS secondary to other RMDs, such as SLE [31, 32]. 
Members of the direct care team reviewed the medical records of patients attending routine 
clinical appointments at a tertiary healthcare centre for the management of APS in the United 
Kingdom. Potentially suitable patients were identified and approached by the members of the 
direct care team to gauge their interest in the study and confirm their eligibility.  Interested 
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participants received a questionnaire pack, which comprised study information, a consent form 
and six questionnaires to self-complete after their appointment. Alternatively, participants 
completed the questionnaires at home and returned them to the researchers in a pre-paid 
envelope. A researcher offered to support questionnaire completion after the clinical 
appointment or via telephone at a mutually convenient time.  Patients who did not return the 
questionnaires were sent a second pack four-six weeks later. No further reminders were issued to 
non-responders. 
Sample Size 
Using G*Power software (version 3.1.9.2) a medium effect (f2=0.15, R2=0.13 equivalent) in 
variance of FS with p=0.05, a power of 0.80, and including four predictor variables required 89 
participants. 
 
Sociodemographic and disease characteristics including age, sex, birthplace, ethnicity, 
employment status (full-time, part-time, retired, unemployed, higher education, other), and 
disability registration (yes/no), duration of APS) were collected using a bespoke, self-
administered questionnaire.  
Variables Participants completed five self-completed, validated and standardised questionnaires. 
Fatigue over the past week was measured using the 13-item Functional Assessment of Chronic 
Illness Therapy (FACIT-Fatigue Scale (FS, 4-point Likert scale ‘not at all fatigued’-‘very much 
fatigued’ with a lower score indicating greater fatigue (range 0-52). A score of <30 indicates 
severe fatigue [33, 34].  
 
Mood was assessed with the 9-item Patient Health Questionnaire (PHQ-9, 4-point Likert scale, 
‘not at all’-‘nearly every day’) which is designed to correspond to the diagnosis of depression. A 
higher score indicates lower mood/depression (range 0-27) and scores ≥10 represents clinically 
depressive symptoms. [35, 36]. 
 
Physical Activity over the preceding 7 days was measured with the 4-item International Physical 
Activity Questionnaire – short form (IPAQ). The metabolic equivalent of task was calculated 
over seven days (METS/minutes/week – IPAQMETS) and scores ≥600MET/minutes/week 
were considered physically active [37]. 
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The quality of sleep over the past month was assessed using the 7-component Pittsburgh Sleep 
Quality Index (PSQI, 19-items, 4-point Likert scale (‘not during the past month’-‘three or more 
times a week’)). A higher total PSQI score (range 0-21) represents lower sleep quality. A total 
PSQI score of >5 represents severe difficulties in at least 2 components [38, 39]. 
 
Perceived social support from family, friends and significant others was evaluated via the 12-
item (7-point Likert scale (‘‘strongly disagree”-“strongly agree’’) Multi-Dimensional Perceived 
Social Support Scale (MSPSS) (range 1-7). Higher scores indicate higher perceived social support 
(1-2.9-low; 3-5-moderate; 5.1-7 high) [40, 41]. 
 
Qualitative phase 
A purposive sub-sample of participants enrolled to the cross-sectional survey were interviewed 
by one of two researchers (JA, SG) [42]. The interviewees varied in relation to most 
sociodemographic characteristics, APS type and lived experiences.  
 
Interviewers were not directly involved in participants’ healthcare and were supervised by an 
experienced qualitative researcher (HL). The audio-recorded interviews were conducted either 
face-to-face or by telephone, subject to participant’s preference. A topic guide was developed a 
priori derived from other RMD fatigue literature [8, 9, 11] and refined with researchers’ and 
patients’ feedback to include questions aligned to the key quantitative variables. The semi-
structured interview schedule allowed the interviewer to ask open-ended questions so the 
interviewee could diverge or expand the experiences or situations in more detail [43]. A pilot 
study was completed with three participants to assess comprehension and relevance of questions, 
timing and subjectively perceived research burden. No further changes were necessary to the 
interview guide (Table 1). Subtle judgement between interviewers and supervisor led to 
recruitment termination when data saturation of themes had been reached, e.g. no new 
information was reported by the participants [44].   
 
Data Analysis 
Statistical analysis  
Analyses were completed using SPSS statistics software v25.0 (IBM statistics Inc, Armonk, NY, 
USA). Statistical significance was set at p<0.05. Frequencies and mean (standard deviation [SD]) 
values were reported for categorical and continuous descriptive variables, respectively. 
Relationships with FS (criterion variable) were explored using 2-tailed Spearman’s Rho 
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correlation coefficients. A backward stepwise regression was performed including all measures 
associated with FS at P<0.05 in the bivariate analyses to determine whether they predicted the 
FS score. The model with the largest adjusted R2 model was used to perform a multiple linear 
regression analysis. Missing values were excluded pairwise. Univariate (Studentised residual 
values ±3SD) and multivariate outliers (Mahalanobis distance p<0.01) were excluded, and 
models were evaluated for multicollinearity, normal and independent errors, and 
homoscedasticity. 
 
Qualitative data analysis 
The interviews were anonymised, transcribed verbatim by one researcher and one professional 
transcribing agency, and the text analysed by two researchers (JA, HL) using the principles of 
Framework Analysis [45] via a five-stage structured approach [46] that included (i) familiarisation 
with text, (ii) coding within the qualitative computer package NVIVO 10 QSR International Pty 
Ltd. Version 10; 2014 [47] (iii) building categories and themes, (iv) identification of a thematic 
framework (v) linking findings with theoretical concepts.  
 
Validation of data included (i) checking initial codes with one external researcher from one 
transcript; (ii) presentation of initial findings from the pilot study to supervisor (iii) discussing 
emerging themes from two additional transcripts and (iv) single counting.  Transcript accuracy 
was checked by the participants against original recordings. A balanced reporting of data is a 
recognized validation strategy [47] therefore a range of accounts are presented, when available. 
 
RESULTS 
Quantitative phase 
Descriptive statistics: 105 potentially eligible patients were approached between July 2014–
June 2017. Two people with communication difficulties (hearing impairment (n=1), insufficient 
English (n=1)) were excluded. 103 participants enrolled onto the study (18 males, mean age 
50.3(SD=10.1) years). Data from 16 participants (10 male, 49.7(10.1) years) were omitted due to 
incomplete data. 87 participants (8 male, 50.3(10.4) years) were included in the analysis (Table 2).  
 
62% of participants reported severe fatigue, 40% of participants reported depression, 24% of 
participants were classified as physically inactive, 69% participants revealed severe sleep 
difficulties and 35% participants reported low-moderate levels of perceived social support.  
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Bivariate associations with fatigue: FS was negatively associated with PHQ9 (rs(84)=-
0.750,p<0.001) and PSQI (rs(79)=-0.515,p=<0.001), and positively associated with IPAQMETS 
(rs(81)=0.232,p=0.037) and MSPSS (rs(82)=0.239,p=0.030) (Table 3). 
Multivariate analyses:  The backward stepwise regression included all variables (Table 4). The 
final best fit model explained 56% of the variance in FS, (adjusted R2=0.560, F(3,74)=33.65, p<0.001) 
and included PHQ9 and IPAQMETS as significant predictors, PSQI as a non-significant predictor 
but not MSPSS (Table 5). Unstandardized beta coefficients indicated that for every unit increase 
in PHQ9 scores, FS decreased by 1.336 points (95% CI -1.72, -0.95, SE B=0.19, β=-0.67, p<0.001) 
and for every unit increase in IPAQMETS, FS increased by 0.001 points (95% CI 0.00004, 0.00119, 
SE B=0.0003, β=0.15, p=0.037). For every unit increase in PSQI scores, FS decreased by 0.286 
points (95% CI -0.84, 0.27, SE B=0.28, β=-0.1, p=0.306). 
 
Qualitative phase 
Twenty consenting participants were interviewed (duration: 20-60 minutes). The participants 
were all female and predominantly white (Table 2). Three key themes that were identified: (i) 
Characteristics of fatigue, (ii) Impact on life and (iii) Coping strategies, with two-four linked 
subthemes.  
 
1) Characteristics of Fatigue 
Use of Metaphors 
All patients expressed experiencing fatigue at some time and used a range of metaphors to 
describe their fatigue, for example: 
 
“fatigue hits you like a truck” (P7),  
 “I feel like a rag doll with no stuffing left”, (P1) 
” I’m climbing up a really big hill with a massive rucksack on my back, and I’m struggling to get 
to the top” (P12) 
  “...[fatigue is] almost like a physical weight pulling me down feeling’ (P19) 
 
 
Unpredictability and fluctuation of fatigue 
Our participants (14/20) described that fatigue was unpredictable and variable and therefore 
interfered with their daily activities of living. They were uncertain about the causes or triggers for 
their fatigue.  
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‘You know the fatigue like I said is, it can happen any day and come out of the blue’. 
(P15) 
 
‘So it’s very variable [fatigue], and it’s not even the fact that I’ve overdone it the day 
before. Which sometimes can help bring on the fatigue even more. But sometimes, umm, 
I’ve been absolutely fine, just been doing a steady pace for days, then boom it suddenly 
hits me and I’m in bed most of the day’. (P13) 
 
 
Severity of fatigue 
Many participants (17/20) commented on the severity of their fatigue and tended to rate this 
using a numerical scale or labels, such as ‘mild’, ‘manageable’, ‘bad ’ and ‘unbearable’ to convey 
the gravity of the fatigue.  
‘……‘I think my fatigue is, on a scale of one to ten, five at the most, three probably most 
of the time’. (P12) 
‘I don’t know [how many times a week]. I have a couple really bad days a week’. (P19) 
 
 
2) Impact on Life 
The impact of fatigue on each individual’s life was personal and wide ranging. All participants 
reported ‘low motivation’ or ‘forcing themselves’ to carry on with everyday life during periods of 
fatigue. Participants described the huge effort required to get through days when they were 
experiencing overwhelming fatigue and lack of energy.  
 Physical activity 
Most participants (16/20) regarded themselves as physically active in their private and/or work 
lives, however, the frequency, intensity, duration and format of physical activity varied between 
interviewees. They were aware of the need to be active for their general health and were broadly 
aware of the public health recommendations.  
‘I do, roughly, you know, between 15 and 20 minutes of walking a day…which is what the 
national, you know, erm…guidelines say’. (P15) 
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They (16/20) described a relationship between physical activity and fatigue levels but noted that, 
at times, fatigue was a barrier to completing physical activity. 
 ‘Sometimes it [my physical activity] will be morning, sometimes it will be the afternoon 
and sometimes early evening, it really depends. But usually sort of around one-ish…..I 
have to walk the dog’. (P6) 
 ‘…when I did have bad fatigue periods, I couldn’t swim for a few weeks’ (P10) 
 
Some participants (7/20) observed that exercise was a helpful management strategy for fatigue, at 
times. 
‘‘…sometimes exercise can help fatigue, but I also know, and I can read my body quite 
well, when sometimes it is going to make me worse’ (P11) 
 
‘…if I’m sedentary, it just makes it [fatigue] worse’ (P14) 
 
Quality of Sleep 
Some participants (5/20) reported that sleep quality influenced their fatigue and that this was 
difficult to manage and frustrating.  
 ‘A poor night’s sleep, makes me, it sort of extenuates tiredness, and it feels worse, and 
when my INR [International Normalised Ratio] is low’. (P14) 
‘I hate it when I am so tired, for instance recently I been on holiday with a friend and I 
was determined not to do it [have a hour sleep during the day], but I’m afraid I did have 
to do it’. (P7) 
 
Impact of Mood 
Some participants (8/20) described how mood and negative thoughts, affected their fatigue. 
These thoughts could be intrusive and unhelpful, and this influenced their ability to accomplish 
their daily activities, for example.  
 
‘…in some ways my mood can affect my fatigue, but it’s making me go more the other 
way at the moment, it’s making me feel like I can’t sleep... I’m constantly thinking about 
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things that are upsetting me or negative thoughts…and of course my body is getting 
tired, so by the time two days later I’m feeling more fatigued than I would have done if I 
hadn’t been feeling so anxious and agitated’ (P15)  
 
A few participants (3/20) also reported that fatigue also influenced their mood. 
‘…..I do believe that fatigue can trigger in me, slight depression, I’m not depressed by 
nature, but obviously the energy and dealing with it day in and day out when it [fatigue] is 
going on it is tiresome, and I find that your mind-set is not so clear, and you are not as 
rational as you would be, if you feel refreshed and positive’. (P11) 
 
Impact on Work 
There was no doubt that fatigue impacted upon participants’ salaried or daily work, which meant 
they had to make adaptations and were feeling unable to carry out complex tasks at times.  
‘[I] work flexi-time, so on a day where I just think I cannot do this anymore, I just need 
to get myself home, I can leave within reason’. (P10) 
‘……..I only work part time, whether I would be able to work full-time? I don’t know 
the answer to that. Maybe I would get too fatigued if I worked full time’. (P6) 
 
3) Coping strategies 
All participants (20/20) employed a range of coping strategies to manage their fatigue. The 
strategies selected depended on the severity of the fatigue and were often informed by past 
successful experiences of dealing with their fatigue. 
Individual coping strategies  
Most patients (16/20) described how they applied individual coping strategies in their personal 
life, and pacing was a popular strategy. 
‘If I’m doing something that needs doing, and I start to get it [fatigue], I just carry on. I 
will suffer for it afterwards, but I don’t want it [fatigue] to take over my life’. (P1) 
 ‘I think you have to pace, you have to be careful and you have to pace yourself, you 
can’t do this, that and the other, and so, but even when you pace yourself you still get 
those times [of fatigue], for no reason, and you look at it and go, oh, it is like that today is 
it’? (P12) 
 
 
Support from healthcare professionals 
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Many participants (19/20) had discussed fatigue with a healthcare professional, however, the 
topic of fatigue often received a mixed response by clinicians and tended not to be routinely 
reviewed.   
‘I did obviously talk about it [fatigue] when I was first diagnosed, and they [clinicians] did 
take it seriously, but now there is not point keeping going on about it to them [clinicians]’ 
(P7) 
 ‘when I spoke to my GP, my GP said ‘well you know more about this than I do.’ So I 
stopped at that point. But, although having said that, the rheumatologists that I saw 
when I had the problem with the steroids, he understood completely about the fatigue. 
Because he actually said to me, I told him about my symptoms with the joints in the 
muscles and things, he said to me ‘oh you must get so tired’ and I said ‘well it’s 
wonderful to hear someone actually say that I should be getting tired!’ (P7) 
 
 
DISCUSSION 
This mixed-methods study is one of the first to explore the experience and impact of fatigue in 
adults with pAPS.  The findings showed that fatigue was common, unpredictable and sometimes 
overwhelming in people with pAPS. It was influenced by factors such as low mood and physical 
inactivity. Participants had developed their own coping strategies to manage their fatigue and 
generally reported receiving high levels of social support. They reported minimal or variable 
understanding from health professionals. 
 
Almost two thirds of our participants reported experiencing severe fatigue at times. Participants 
were vigilant about monitoring their fatigue so they could adopt strategies to mitigate the 
symptom. However, they found fatigue challenging to manage and difficult to explain to others, 
including health professionals. Consequently, participants used metaphors to express the 
character of fatigue and convey their increased effort and loss of energy, similar to people with 
long-term conditions such as SLE [9] or RA [11].   
Over a third of our participants reported low mood and this was associated with higher fatigue 
levels. The relationship between mood and fatigue is well described in people with other long-
term conditions [16, 48] and mood predicts fatigue even after adjustment for pain, and other 
potentially confounding variables in some RMDs [20]. Low mood can affect sleep and many of 
our participants reported sleep difficulties like people with other RMDs [15, 17, 20]. Sleep 
disturbances could be due to pain, stress or influenced by medication [17]. Whilst many 
interviewees described a clear link between fatigue and sleep, sleep quality did not independently 
predict fatigue in our quantitative data. This may be because sleep quality has an indirect effect 
Fatigue in pAPS_mixed methods 
 
on fatigue and mediates the direct influence of depression or physical inactivity on fatigue [15] 
[17].  
Over three quarters of our respondents reported meeting physical activity recommendations, 
which is higher than people with others RMDs [22, 23, 49]. This may be due to over-reporting 
because this data was collected using self-completed questionnaires, which is subject to recall 
bias. Alternatively, as many participants were employed or had active caring responsibilities, this 
finding may reflect activity undertaken for transportation (i.e. walking) related to their daily work. 
This study showed that greater physical activity was directly related to lower fatigue and some 
interviewees stated that physical activity/exercise was a helpful management strategy for fatigue. 
Brief, home-based physical activity and exercise interventions improve fatigue and sleep quality 
in people with RA, so this may be a promising intervention approach for people with pAPS [50, 
51]. However, some interviewees found the physical activity hard to complete due to the 
unpredictability of fatigue so tailored strategies or interventions may be needed to accommodate 
fluctuations in fatigue. 
Participants developed their own coping strategies, particularly pacing, to manage their fatigue. 
They mostly received good social support from family, friends and significant others (i.e. perceived 
emotional support), concurring with other research [52] and it is proposed that social support  
influences self-efficacy and has a buffering effect on fatigue [20, 26]. Whilst social support 
correlated with fatigue in our study, it did not independently explain the variance in fatigue in our 
multivariate analyses and exploration of the other types of perceived social support (i.e. 
instrumental (practical support such as housework) or informational (i.e. education) support) may 
clarify this relationship [52]. Informational social support could be provided by clinicians although 
our participants commented that fatigue was not regularly discussed in consultations. This could 
be because clinicians do not recognise the presence or impact of fatigue in people with pAPS or 
because it is not acknowledged in management recommendations [27]. Alternatively, the lack of 
evidence-based management strategies for fatigue in pAPS may mean that it is rarely a treatment 
focus.  A multidisciplinary team approach may optimise the management of pAPS, similar to other 
RMDs, such as RA [53-55]. 
The conceptual model of fatigue for patients with RA by Hewlett et al. 2011 aligns with our 
findings [14]. Factors, such as pAPS itself; cognitive and behavioural dimensions (e.g. mood, 
physical activity) and personal aspects (e.g. social support) play a dynamic role in the experiences 
of fatigue and how people cope with it.  This model may help researchers, clinicians and patients 
clarify the focus for future interventions, measurements, inform treatment and self-management.  
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This study has several strengths. The mixed methodology approach facilitated the integration of 
the findings from both phases within a single study.  The findings are complementary and 
provide a deeper insight of the experience of fatigue in adults with pAPS [28, 29].  
Our eligibility criteria were robust and adults with co-morbidities known to influence fatigue (e.g. 
obesity) were excluded to minimise confounding factors. The number of medical records 
reviewed and reasons for patients’ ineligibility following review of medical notes were not 
documented. However, the team enrolled a range of participants with pAPS and only two 
potentially suitable patients, who were identified and approached by the clinic team, were 
excluded. Our cohort reflected the female predominance which exists in pAPS. However, 
patients were recruited from a single centre, there was relatively limited ethnic and gender 
diversity in our study population and the educational status of the participants was not recorded.   
Our survey explored key factors known to influence fatigue in other RMDs, but other aspects 
may contribute to fatigue (e.g. physical capacity, end organ damage) and these require 
investigation. As data from our quantitative phase was cross-sectional, no causality can be 
inferred from the findings and the reciprocal effects of fatigue on other features cannot be 
observed (e.g. greater fatigue may lead to lower mood or less activity).  
Fatigue is common and impacts the lives of adults with pAPS. Enhancing communication 
between patients and clinicians so that symptoms which are important to patients, such as 
fatigue, are identified and addressed appropriately is crucial to optimise the management of 
pAPS. Developing effective multidisciplinary interventions to support self-management with 
patients, clinicians and researchers of fatigue in people with pAPS is vital.  
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Table 1 Interview topic guide to explore the experience of fatigue in adults with 
primary antiphospholipid syndrome 
1. Do you ever feel fatigued? 
2. How do you feel about moving around and being active? 
3. Tell me about your experiences of fatigue? Can you describe it to me? 
4. What do you think causes your fatigue? 
5. How do the symptoms of your fatigue vary? 
6. Does fatigue impact on your life? How? 
7. How do you feel about your personal level of physical activity/ exercise? 
8. Do you manage to integrate physical activity/exercise in your daily routine? 
9. Do you talk to other people about your fatigue/activity levels? 
10. What is your experience of talking to doctors and nurses about your fatigue? 
11. What is your experience of talking to doctors and nurses about your physical activity/ 
exercise? 
12. Have doctors or nurses suggested physical activity/ exercise as a way of managing 
fatigue? 
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Table 2 Sociodemographic and clinical characteristics of adults with primary antiphospholipid syndrome  
 Cross–sectional survey respondents Interview participants 
 Total (n=87) Total (n=20) 
Gender (female)  79.0 (90.8)* 20.0 (100)* 
Age (years) 50.3 (10.4) 49.3 (9.7) 
Disease duration (months) 143.0 (92.0) 149.4 (97.5) 
Ethnicity (White British) 75.0 (86.0)* 18.0 (90.0)* 
Registered disabled (Yes) 13.0 (14.0)* 5.0 (25.0)* 
Employment Status   Full time 
 Part time  
31.0 (36.0)* 6.0 (30.0)* 
16.0 (18.0)* 7.0 (35.0)* 
 Retired 15.0 (17.0)* 2.0 (10.0)* 
 Unemployed 13.0 (15.0)* 2.0 (10)* 
 Higher education 2.0 (2.0)* 0.0 (0.0)* 
 Other 10.0 (12.0)* 3.0 (15.0)* 
FS 25.7 (13.0) b 24.0 (11.5) 
PHQ-9 9.5 (6.6) 9.4 (5.2) 
IPAQMETs 2982.4 (3433.8)a 2236.3 (2540.2) 
PSQI 8.8 (4.6) c 9.3 (3.9) 
MSPSS 5.4 (1.4) a 5.2 (1.7) 
FS FACIT – F Fatigue subscale, IPAQMETs – International Physical Activity Questionnaire (Metabolic Equivalent of 
Task/minutes/week), MSPSS – The Multi-Dimensional Perceived Social Support Scale,  
PHQ-9 – Patient Health Questionnaire, PSQI – Pittsburgh Sleep Quality Index.  
All mean (standard deviation) except * n(%)  an=85, bn=84, cn=71 
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Table 3 Descriptive statistics and bivariate correlations between 
fatigue, mood, physical activity, sleep quality, and social support in 
adults with primary antiphospholipid syndrome 
 FS PHQ-9 IPAQMETs PSQI MSPSS 
FS 1 -0.750** 0.232* -0.515** 0.239* 
PHQ-9  1 -0.105 0.613** -0.238* 
IPAQMETs   1 -0.098 0.018 
PSQI    1 -0.071 
MSPSS     1 
*P<0.05, ** P<0.01 
FS – FACIT -F Fatigue subscale, IPAQMETs – International Physical 
Activity Questionnaire, MSPSS – The Multi-Dimensional Perceived Social 
Support Scale, PHQ-9 – Patient Health Questionnaire, PSQI – Pittsburgh 
Sleep Quality Index. 
 
 
Table 4 Backward multiple linear regression models for predicting fatigue (FS) in adults with primary 
antiphospholipid syndrome 
Model R R Square Adjusted R Square SE of the Estimate F p 
Baseline Model 0.762a 0.581 0.558 8.637 F(4,73)=25.33 <0.001 
Best Fit Model 0.760b 0.577 0.560 8.622 F(3,74)=33.65 <0.001 
a Predictors:  IPAQMETS, PHQ-9, MSPSS, PSQI 
b Predictors:  IPAQMETS, PHQ-9, PSQI 
FS – FACIT -F Fatigue subscale, IPAQMETs – International Physical Activity Questionnaire, MSPSS – The Multi-
Dimensional Perceived Social Support Scale, PHQ-9 – Patient Health Questionnaire, PSQI – Pittsburgh Sleep Quality Index.   
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Table 5 Beta coefficients for the baseline model and best fit model, for predicting fatigue (FS) in adults with primary antiphospholipid 
syndrome 
 
Unstandardized 
Coefficients 
Standardized 
Coefficients t p 
95.0% Confidence Interval 
for B 
B Std. Error Beta     
Lower 
Bound 
Upper 
Bound 
Baseline Model PHQ-9 -1.297 0.197 -0.655 -6.567 <0.001 -1.690 -0.903 
  IPAQMETs 0.001 0.0003 0.159 2.085 0.041 0.00003 0.00118 
  PSQI -0.317 0.280 -0.111 -1.132 0.262 -0.876 0.241 
  MSPSS 0.616 0.716 0.067 0.861 0.392 -0.810 2.042 
Best Fit Model PHQ-9 -1.336 0.192 -0.674 -6.966 <0.001 -1.718 -0.954 
  IPAQMETS 0.001 0.0003 0.162 2.127 0.037 0.00004 0.00119 
  PSQI -0.286 0.278 -0.100 -1.032 0.306 -0.839 0.267 
         
FS – FACIT -F Fatigue subscale, IPAQMETs – International Physical Activity Questionnaire, MSPSS – The Multi-Dimensional Perceived Social 
Support Scale, PHQ-9 – Patient Health Questionnaire, PSQI – Pittsburgh Sleep Quality Index.  
 
 
 
